This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Trial of TDF/FTC + Raltegravir Versus TDF/FTC + Efavirenz in HIV-1-Infected Women (ICE-002)

This study has been withdrawn prior to enrollment.
(Decision not to go forth with study.)
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by:
Rush University Medical Center
ClinicalTrials.gov Identifier:
NCT00984152
First received: May 7, 2009
Last updated: May 4, 2015
Last verified: May 2015
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: December 2013
  Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)